NYMOX PHARMACEUTICAL CORP (NYMX)

BSP733981026 - Common Stock

0.2  -0.05 (-19.68%)

After market: 0.1767 -0.02 (-11.65%)

News Image
8 months ago - Nymox Pharmaceutical Corporation

Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results

NYMOZARFEX 15 mg Minimal Treatment of Low Grade Prostate Cancer Leads to Significant Long-Term Reduction in Incidence of Associated Prostate Cancer Surgery and Radiotherapy

News Image
8 months ago - Nymox Pharmaceutical Corporation

Nymox Reports on U.S. Patent Issuances

News Image
9 months ago - Nymox Pharmaceutical Corporation

Nymox Update

News Image
9 months ago - Nymox Pharmaceutical Corporation

NYMOX Update

News Image
9 months ago - InvestorPlace

Why Is Kazia Therapeutics (KZIA) Stock Moving Today?

Kazia Therapeutics (KZIA) stock is on the move Thursday after the company received fast-track designation for its paxalisib program.

News Image
9 months ago - InvestorPlace

Why Is Nymox Pharmaceutical (NYMX) Stock Down 18% Today?

Nymox Pharmaceutical (NYMX) stock is falling on Thursday after the company told investors its shares will be delisted tomorrow.

News Image
9 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday!

News Image
9 months ago - Nymox Pharmaceutical Corporation

Nymox Delisting from NASDAQ

News Image
9 months ago - Nymox Pharmaceutical Corporation

Nymox Delisting from NASDAQ

IRVINE, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) today received a Nasdaq Hearing Delist...

News Image
a year ago - Nymox Pharmaceutical Corporation

Nymox Provides Current Update

News Image
a year ago - Nymox Pharmaceutical Corporation

Nymox Provides Current Update

IRVINE, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide a mid-2nd quarter...

News Image
a year ago - Nymox Pharmaceutical Corporation

Nymox Provides Corporate Update

News Image
a year ago - Nymox Pharmaceutical Corporation

Nymox Provides Corporate Update

IRVINE, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide a current update...

News Image
a year ago - Nymox Pharmaceutical Corporation

Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer

IRVINE, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce the appointment...

News Image
a year ago - Seeking Alpha

Nymox Pharmaceutical gets additional time to regain Nasdaq compliance (NASDAQ:NYMX)

Nymox Pharmaceutical (NYMX) has been granted an additional period until July 3, 2023 to regain compliance with Nasdaq listing requirements. The firm expects to announce further...

News Image
a year ago - Nymox Pharmaceutical Corporation

Nymox Officially Granted Extension to Regain Listing Requirements

News Image
a year ago - Nymox Pharmaceutical Corporation

Nymox Officially Granted Extension to Regain Listing Requirements

IRVINE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) has officially been granted by NASDAQ...

News Image
a year ago - Nymox Pharmaceutical Corporation

Nymox Announces NYMOZARFEX Marketing Application is Accepted For Review

IRVINE, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that the...